CinCor Plans Baxdrostat Phase III Despite Phase II Miss In Uncontrolled Hypertension

 
• By Joseph Haas
High blood pressure
CinCor hopes to advance baxdrostat in hypertension despite Phase II setback • Source: Shutterstock

More from Clinical Trials

More from R&D